Dhakal, B., Akhtar, O. S., Fandrei, D., Jensen, A., Banerjee, R., Pan, D., Richard, S., Friend, R., Rees, M., Costello, P., Martinez, M. V., Pasvolsky, O., Wagner, C., Davis, J. A., Puglianini, O. C., Reshef, R., Afrough, A., Dima, D., Bhutani, M., Nadeem, O., Parrondo, R., Freeman, C., Mikkilineni, L., Raza, S., Jr, L. D. A., Kapoor, P., Hosoya, H., Chhabra, S., Grajales-Cruz, A., Gaballa, M., Midha, S., Alsina, M., Sborov, D., Patel, K., Lin, Y., Ferreri, C., Gagelmann, N., Kumar, A., Hansen, D., Cowan, A., Costa, L. J., Merz, M., Sidana, S. (2025). Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy. Blood. https://doi.org/10.1182/blood.2025029773